Point72 Asia (Singapore) Pte. Ltd. Gritstone Bio, Inc. Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $480 Billion
- Q2 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Gritstone Bio, Inc. stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 155,915 shares of GRTS stock, worth $90,430. This represents 0.02% of its overall portfolio holdings.
Number of Shares
155,915Holding current value
$90,430% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding GRTS
# of Institutions
83Shares Held
37.5MCall Options Held
1.46MPut Options Held
168K-
Redmile Group, LLC San Francisco, CA5.11MShares$2.96 Million0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.64MShares$2.69 Million0.0% of portfolio
-
Morgan Stanley New York, NY4.45MShares$2.58 Million0.0% of portfolio
-
Versant Venture Management, LLC San Francisco, CA3.56MShares$2.07 Million4.9% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL3.46MShares$2.01 Million0.01% of portfolio
About Gritstone bio, Inc.
- Ticker GRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,006,896
- Market Cap $42.3M
- Description
- Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...